Company
Products & Services
R & D
News & Investors
Careers
Contact
Diagnostic Products
Latest News
05.01.2012
Epigenomics Biomarker Predicts Drug Resistance in Colorectal Cancer
04.01.2012
Epigenomics announces initiation of PMA filing for Epi proColon, provides update on regulatory timeline
09.12.2011
Epigenomics AG Completes U.S. Clinical Validation Study for Colorectal Cancer Blood Test Epi proColon; Provides Update on U.S. Regulatory Plans
